Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Duffau

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 15, 2013
Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestationsJ M d'Elbée, M Parrens, P Mercié, et al.
BMC Infectious Diseases|November 17, 2020
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohortF Bonnet, F Le Marec, O Leleux, et al.
HIV Medicine|March 8, 2026
Real-world use of second-generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS-CO3-AquiVIH-NA cohortO Leleux, A Peyrouny-Mazeau, A Perrier, et al.
Thrombosis Research|March 31, 2024
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patientsH Lévesque, J F Viallard, E Houivet, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 15, 2013
Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestationsJ M d'Elbée, M Parrens, P Mercié, et al.
BMC Infectious Diseases|November 17, 2020
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohortF Bonnet, F Le Marec, O Leleux, et al.
HIV Medicine|March 8, 2026
Real-world use of second-generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS-CO3-AquiVIH-NA cohortO Leleux, A Peyrouny-Mazeau, A Perrier, et al.
Thrombosis Research|March 31, 2024
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patientsH Lévesque, J F Viallard, E Houivet, et al.
Pageof 3